Current:Home > InvestTradeEdge Exchange:FDA warns CVS, Walgreens and others about these unapproved eye products -TradeWise
TradeEdge Exchange:FDA warns CVS, Walgreens and others about these unapproved eye products
SignalHub Quantitative Think Tank Center View
Date:2025-04-10 21:34:54
The TradeEdge ExchangeU.S. Food and Drug Administration warned CVS, Walgreens and other companies that they violated federal law by marketing unapproved eye products.
The eye products are being illegally marketed as being able to treat cataracts, glaucoma, conjunctivitis and more. The FDA said some of the eye products are labeled to contain silver and long-term use can cause skin and body tissues, including the eye, to permanently turn gray or blue-gray.
The companies have 15 days to respond to the FDA's warning letter as it continues its investigation.
What eye products are being investigated?
The FDA issued warning letters for specific eye drops at the following companies:
- CVS Health − CVS Health Pink Eye Drops
- Walgreens Boots Alliance, Inc. − Walgreens Pink Eye Drops
- Boiron, Inc. − Optique 1 Eye Drops
- DR Vitamins Solutions − Vision Clarity Eye Drops, Life Extension Brite Eyes III, Can-C Eye Drops, Longevity Science Visual Ocuity
- Natural Ophthalmics, Inc. − Women’s Tear Stimulation Dry Eye Drops, Allergy Desensitization Eye Drops, Ortho-K Thin (Daytime) Eye Drops, Ortho-K Thick (Night) Eye Drops, Tear Stimulation Forté Dry Eye Drops, and Cataract Eye Drops with Cineraria
- OcluMed LLC − OcluMed Eye Drops
- Similasan AG/Similasan USA − Similasan Dry Eye Relief, Similasan Complete Eye Relief, Similasan Allergy Eye Relief, Similasan Kids Allergy Eye Relief, Similasan Red Eye Relief, Similasan Pink Eye Relief, Similasan Kids Pink Eye Relief, Similasan Aging Eye Relief, Similasan Computer Eye Relief, Similasan Stye Eye Relief, Similasan Pink Eye Nighttime Gel, and Similasan Dry Eye Nighttime Gel
- TRP Company, Inc. − Dryness Relief, Pink Eye Relief, Allergy Eyes Relief, Red Eye Relief, Eye Strain Relief, Eye Lid Relief, Aging Eye Relief, Blur Relief, Floaters Relief, Twitching Relief, and Stye Relief
Multiple eye products recalled this year
This year, multiple eye products were recalled for causing harm to people, including blindness, infections and sometimes death.
In February, EzriCare Artificial tears were voluntarily recalled by the manufacturer after receiving 55 reports of eye infection, blindness and a death caused by a bloodstream infection. The India-based Global Pharma Healthcare, later issued another recall due to possible contamination. The eye drops, which were linked to a drug-resistant germ pseudomonas aeruginosa, resulted in four deaths, according to the Centers for Disease Control and Prevention.
By March, Pharmedica USA LLC and Apotex Corp. pulled eyedrops off the shelves for potential lack of sterility. In August, the FDA warned consumers not to purchase and immediately stop using Dr. Berne’s MSM Drops 5% Solution and LightEyez MSM Eye Drops-Eye Repair due to contamination.
2 more eye drop products recalledafter being linked to potentially deadly bacteria
Recalled contaminated eye dropslinked to bacteria have led to a fourth death, CDC says
veryGood! (3)
Related
- South Korean president's party divided over defiant martial law speech
- AP Week in Pictures: Asia
- Federal prosecutor in Arkansas stepped down while being investigated, report says
- Watchdog: EPA’s lead pipe fix sent about $3 billion to states based on unverified data
- Pressure on a veteran and senator shows what’s next for those who oppose Trump
- Greek defense team says 9 Egyptians accused of causing deadly shipwreck were misidentified as crew
- Shaken by the Fico assassination attempt, the EU wonders if June elections can be free of violence
- Ex-Michigan State coach Mel Tucker wins court fight over release of text messages
- Which apps offer encrypted messaging? How to switch and what to know after feds’ warning
- Greek defense team says 9 Egyptians accused of causing deadly shipwreck were misidentified as crew
Ranking
- The Louvre will be renovated and the 'Mona Lisa' will have her own room
- A new South Africa health law aims at deep inequality, but critics say they’ll challenge it
- Want to try a non-alcoholic beer? Here's how to get a free one Thursday
- Man convicted of attacking ex-Speaker Nancy Pelosi’s husband with a hammer is to be sentenced
- Paula Abdul settles lawsuit with former 'So You Think You Can Dance' co
- Drones smuggled drugs across Niagara River from Canada, 3 suspects caught in NY
- Germany’s parliament lifts immunity for prosecution of a far-right lawmaker
- Drake, Kendrick Lamar and More Score 2024 BET Awards Nominations: See the Complete List
Recommendation
Juan Soto praise of Mets' future a tough sight for Yankees, but World Series goal remains
Federal prosecutor in Arkansas stepped down while being investigated, report says
West Virginia miner dies in state’s first reported coal fatality of the year
Blue Origin preparing return to crewed space flights, nearly 2 years after failed mission
NHL in ASL returns, delivering American Sign Language analysis for Deaf community at Winter Classic
'One Chip Challenge' led to the death of teen Harris Wolobah, state official says
Tom McMillen, head of the FBS athletic directors’ organization LEAD1, announces he’s stepping down
These Beverly Hills, 90210 Secrets Are Saucier Than Kissing Your Ex at Your Best Friend's Wedding